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Purpose. To investigate the correlation of Apperent Diﬀusion Coeﬃcient (ADC) values in invasive ductal breast carcinomas with
detailed histologic features and enhancement ratios on dynamic contrast-enhanced MRI. Methods and Materials.D y n a m i cM R
images and diﬀusion-weighted images (DWIs) of invasive ductal breast carcinomas were reviewed in 25 (26 lesions) women. In
each patient, DWI, T2WI, T1WI, and dynamic images were obtained. The ADC values of the 26 carcinomas were calculated with
b-factors of 0 and 1000 s/mm2 using echoplanar DWI. Correlations of the ADC values were examined on dynamic MRI with
enhancement ratios (early to delayed phase: E/D ratio) and detailed histologic ﬁndings for each lesion, including cellular density,
the size of cancer nests, and architectural features of the stroma (broad, narrow, and delicate) between cancer nests. Results.T h e
mean ADC was 0.915 ± 0.151 × 10
−3 mm2/sec. Cellular density was signiﬁcantly correlated with ADC values (P = .0184) and
E/D ratios (P = .0315). The ADC values were also signiﬁcantly correlated to features of the stroma (broad to narrow, P = .0366).
Conclusion. The ﬁndings suggest that DWIs reﬂect the growth patterns of carcinomas, including cellular density and architectural
features of the stroma, and E/D ratios may also be closely correlated to cellular density.
1.Introduction
Diﬀusion-weighted(DW)imaginghasbecomeanimportant
method for diagnosis of breast lesions. Recent studies [1–
5] have shown the usefulness of DW imaging for detecting
breast tumors and distinguishing between malignant and
benign breast lesions. In many tumors, histologic diﬀeren-
tiation reﬂects the cellular density, and several studies [6–9]
havedemonstratedarelationshipbetweenapparentdiﬀusion
coeﬃcient (ADC) values and tumor cellular density.
Typically, invasive ductal carcinoma shows early strong
enhancement due to the expression of many angiogenic or
growth factors, including vascular endothelial growth factor
(VEGF) and tumor neovascularity. Pathologically, invasive
ductal breast carcinomas are comprised of cancer nests,
stromas between these nests, and some ductal components.2 Journal of Oncology
We have shown that histologic morphologic features such
as the size of the cancer nests, the width of the stroma,
ﬁbrosis, angiogenesis, and patterns of VEGF expression
aﬀect enhancement patterns of breast carcinomas [10].
Additionally, these histologic parameters are closely related
with growth patterns of breast carcinomas.
The aim of the study was to investigate the histologic
features that aﬀect the ADC in invasive ductal breast
carcinomas. To our knowledge, correlations of ADC values
with enhancement patterns on dynamic contrast-enhanced
MR images and morphologic histologic features in invasive
ductal breast carcinomas have not been reported previously.
2.MaterialandMethods
2.1. Patients. Twenty-ﬁve consecutive women (26 lesions)
(age 30–74 years old, mean 59.2 ± 10.9 years old) with
invasive ductal breast carcinoma who underwent partial
or total mastectomy after MR imaging at our institution
between September 2005 and August 2006 were selected for
examination. The lesion was initially detected by physical
examination, mammography, or ultrasonography. None of
the patients had undergone chemotherapy or large-core nee-
dle biopsy for tissue sampling before the MR examination.
2.2. MR Imaging. MR imaging was performed using a 1.5T
whole-body imager (Magnetom Symphony; Siemens AG,
Erlangen, Germany). The aﬀected side in each patient was
examined using a dedicated breast coil with the patient
in the prone position. DW images were acquired using a
multisection single-shot short tau inversion recovery (STIR)
echoplanar sequence in the transverse or sagittal plane.
FollowingDWimaging,fat-suppressedT2-andT1-weighted
and dynamic images were obtained. Subtraction images
were produced from dynamic images for identiﬁcation of
enhancement. The imaging parameters were as follows: DWI
(TR/TE/TI = 5400/80/180msec, matrix = 50 × 128, slice
thickness (SL) = 5mm, FOV = 131 × 300mm, b factor =
0 and 1000s/mm2, with a motion probing gradient (MPG)
applied along the X, Y,a n dZ axes), 2D fat-suppressed
T2-weighted turbo spin-echo pulse sequence (TR/TE =
4500/84msec, matrix = 460 × 512, SL = 5mm, ﬁeld of
view (FOV) = 200 × 200mm), and a three-dimensional fat-
suppressed T1-weighted FLASH pulse sequence (TR/TE =
5.9/2.4msec, matrix = 141 × 256, SL = 1.5mm, FOV = 150
× 220mm). The latter sequence was performed before and
during intravenous contrast enhancement with 0.1mmol
gadopentetate dimeglumine (Magnevist; Schering, Berlin,
Germany) per kilogram of body weight. A bolus of contrast
agent was injected intravenously using a dedicated infusion
pump at a rate of 1ml/s, followed by a 20-ml saline solution
ﬂush. Sequential multisection, whole-breast images were
obtained in the sagittal plane at 30-second intervals for 5
minutes. In all patients, late sagittal T1-weighted (TR/TE =
420/10msec, matrix = 384 × 512, SL = 5mm, FOV = 200 ×
200mm)andtransverseT1-weighted(TR/TE=420/10msec,
matrix = 384 × 512, SL = 5mm, FOV = 131 × 300mm)
images were obtained for the bilateral breasts.
2.3. Image Analysis
Interpretation of MR Images. Two of the authors (R. N.
Matsubayashi and T. Fujii) interpreted the MR images. We
recorded the size, shape, and enhancement pattern of each
lesion but did not use the ACR MRI BI-RADS classiﬁcation.
Measurement of the ADC. Based on the DW images, we
measured the ADC values of 26 carcinomas. ADC values
were calculated with b-factors of 0 and 1000s/mm2 using
echoplanar DW images. A region of interest (ROI) of as large
a size as possible was positioned over the tumor to avoid
necrosis or scar (nonenhanced area) and artifacts, based on
dynamic MR images (Figures 1(a) and 1(b)). Positioning of
the ROI of each lesion was performed by a radiologist (R. N.
Matsubayashi).
When the lesions were ring-like on DW images, we
positioned the ROI in the peripheral portion. The signal
intensities in the ROI corresponded to the two diﬀerent b
values.
Enhancement Ratio on MR Images. The enhancement ratio
on dynamic contrast-enhanced MR images in the early
(60sec) to the delayed (300sec) phase (E/D ratio) was
calculated for each lesion. When the lesion showed rim
enhancement, the E/D ratio was calculated at the peripheral
region.
2.4. Histopathologic Analysis. Two of the authors (R. N. Mat-
subayashi: who has degree of pathology and S. Momosaki:
general pathologist) performed the histopathologic analysis.
Evaluation of morphologic features was performed using
slices stained with hematoxylin-eosin. Cellular density, the
size of the cancer nests, and the architectural features of the
stroma between the cancer nests were examined (Figure 2).
To determine the cellular density, the number of nuclei of
cancer cells in 10 high-power ﬁelds (x400) for each lesion
was counted, and the mean value was recorded. To assess
the size of cancer nests and architectural features of the
stroma, the major axis of 10 cancer nests and the width of
the stroma at 10 points were also measured for each lesion.
Based on the mean length of the major axis, the sizes of
the cancer nests were determined and classiﬁed as small
(<40μm), medium (40–100μm), or large (>100μm). The
mean width and morphology of the stroma between the
cancer nests were determined, and the stroma was classiﬁed
asdelicate(<10μm),narrow(10–50μm),orbroad(>50μm).
2.5. Statistical Analysis. Statistical comparisons were per-
formed using Fisher’s protected least signiﬁcant diﬀerence
test or Spearman’s log rank test. The correlation of ADC
values with the E/D ratio on dynamic contrast-enhanced
MR images was examined. ADC values were also compared
between groups, for which the status of each histologic
parameter, size of cancer nests, and stroma features were
determined. A P-value of less than .05 was considered to be
statistically signiﬁcant. Data are expressed as means ± SD.
Statistical analysis was performed using StatView software.Journal of Oncology 3
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Figure 1: MR images of representative cases. (a) Case 3: a 59-year-old woman with invasive carcinoma of the left breast. E/D ratio: 1.03,
ADC value 0.850 × 10−3 mm2/s. A well-demarcated mass with strong enhancement is observed. The mass shows high intensity on DWI (b =
1000). (b) Case 13: a 72-year-old woman with invasive carcinoma in the right breast. E/D ratio: 0.90, ADC value 0.975 × 10−3 mm2/s. A mass
with early rim enhancement with delayed internal enhancement is shown. The mass shows high intensity on DWI (b = 1000). The central
portion shows relatively low signal intensity than that in the periphery. The central area showing delayed enhancement may have abundant
ﬁbrous stroma.4 Journal of Oncology
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Figure 2: Cancer nests at invasive sites are classiﬁed based on the mean length of the major axis: small, medium, or large. Features of the
stroma between the nests are classiﬁed as delicate, narrow, or broad (nests: asterisk, stroma: black arrows). (a) Nests: large, stroma: broad.
(b) Nests: medium, stroma: delicate. (c) Nests: small, stroma: narrow. All sections are hematoxylin-eosin stained.
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Figure 3: ADC values were signiﬁcantly correlated with stroma
features (broad to narrow, P = .0366). D: delicate, N: narrow,
B: broad. ADC: ×10
−3 mm2/ s .S :s m a l l ,M :m e d i u m ,L :l a r g e ,
D: delicate, N: narrow, B: broad, E/D: enhancement ratio of
early/delayed phase.
3. Results
Clinical data, MR imaging and histologic features, ADCs,
and the E/D ratio on contrast-enhanced MR images for all
patients are summarized in Table 1. The sizes of lesions were
0.8–3.5cm (mean 1.9 ± 0.8cm). The mean ADC value of
the lesions was 0.915 ± 0.151 × 10−3 mm2/s, and the mean
enhancement ratio was 0.962 ± 0.1. Cellular densities were
signiﬁcantly correlated with ADC values (P = .0184) and
E/D ratios (P = .0315). ADC values were also signiﬁcantly
correlated with stroma features (broadto narrow, P = .0366)
(Figure 3). There was no correlation between ADC values
and E/D ratios and the size of cancer nests.
4. Discussion
MR imaging is useful for diagnosis of breast carcinomas
[11] and to assist in selection of appropriate treatment.
Due to overexpression of growth factors, breast carcinomas
show high angiogenesis, especially at invasive sites. The
expression level of one of the angiogenic factors, VEGF,
correlates with the histologic grade and a variety of clinical
and prognostic factors [12–15]. Dynamic contrast-enhanced
MR imaging has been used to evaluate the vascular supply
tobreastcarcinomas.Invasiveductalbreastcarcinomasshow
strongearlyenhancementwithprolongedorreduceddelayed
enhancement in such imaging, and these enhancement
patterns are closely correlated with histologic morphologic
features [10].
DWI is a useful tool for diagnosis of cerebral infarcts
and other intracranial lesions and has recently been used
for diagnosis and detection of neoplasms in several organs.
In many carcinomas, cellular density is higher in lesions of
higher grade, and DWI may reﬂect the carcinoma growth
pattern. DWI has also been used for body imaging, since
it allows clear detection of breast carcinomas and is helpful
in determination of the extent of the carcinoma and in the
diﬀerentiation between malignant and benign lesions [1–5].
DWI is also used to calculate ADC values, which can reﬂect
cellular density; thus, this technique provides a lot of useful
information for treatment decisions.
Kuroki et al. [3] showed that diﬀusion in breast carci-
noma is signiﬁcantly lower than that in benign masses, and
a signiﬁcant diﬀerence in diﬀusion has been seen between
invasive ductal carcinoma and pure or predominant non-
invasive ductal carcinoma. Several reports have also shown
a correlation between the stage of liver ﬁbrosis and ADCs
[16, 17]. Since breast carcinoma often has ﬁbrotic stroma,
we hypothesized that the degree of ﬁbrosis might also be
reﬂected by the ADC.
Both cellular density and histologic architectural varia-
tionofcancernestsandstromamaybeaﬀectedbythegrowth
pattern, including the histologic grade of the individual
breast carcinoma. In the present study, enhancement ratios
of breast carcinomas on dynamic MR images closely corre-
lated with cellular density and the histologic, morphologic
features. These results suggest that both DW imaging and
dynamic studies can provide detailed histological or bio-
logical information about the lesions. Prediction of growth
patterns of tumors from imaging ﬁndings may be useful forJournal of Oncology 5
Table 1: Clinical data, MR imaging and histologic features, ADCs, and the E/D ratio on contrast-enhanced MR images.
Case Number Age Tumor diameter (cm) Cellular density Size of nest Type of stroma E/D ADC
16 1 1 . 4 × 1.0 1038 M N 0.98 0.564
26 9 3 . 0 × 2.3 315 M N 0.96 0.830
35 9 1 . 6 × 0.9 527 L D 1.03 0.850
46 2 0 . 8 × 0.7 301 S B 1.02 0.940
56 0 2 . 8 × 2.6 324 S B 0.88 0.910
64 9 0 . 8 × 0.8 902 M D 1.10 0.863
73 0 1 . 5 × 1.3 428 S B 0.91 0.885
86 7 3 . 5 × 3.4 502 L B 0.92 0.718
95 8 2 . 0 × 1.6 766 M D 1.06 0.971
10 65 2.5 × 1.9 278 S B 0.84 1.118
11 45 1.7 × 1.3 336 M N 0.99 0.930
12 58 1.0 × 0.8 303 M N 0.96 0.858
13 72 2.3 × 2.0 211 M D 0.90 0.975
14 61 2.5 × 1.9 224 L N 0.76 1.218
15 67 2.0 × 1.7 504 L D 1.11 0.828
16 41 1.9 × 1.7 508 S N 0.92 0.837
17 73 0.9 × 0.8 856 M D 0.93 0.866
18 68 1.8 × 1.2 886 L B 0.99 0.874
19 69 2.5 × 1.7 566 L D 1.08 0.934
20 63 3.2 × 2.9 452 S B 0.84 0.865
21 63 2.2 × 1.5 621 S B 0.73 0.928
22 56 2.2 × 1.3 877 S N 0.97 0.835
23 74 1.2 × 0.8 456 L B 1.04 1.294
24 45 1.5 × 1.5 356 M N 0.97 0.879
25 45 1.3 × 0.8 776 S B 1.11 1.111
26 59 2.1 × 1.3 935 L N 1.02 0.840
planningtreatmentforbreastcarcinoma,andwesuggestthat
a combination of these imaging techniques may become an
important tool to evaluate the eﬀectiveness of chemotherapy
or irradiation for breast carcinoma.
The study is limited by the relatively small number of
patients. Also, itwasdiﬃcult toevaluateADCs oftiny lesions
on our DW images because the images were distorted in
the breast periphery. Parallel imaging techniques including
SENSE may be able to reduce these artifacts (including
motion artifacts) and shorten the scanning time. Addition-
ally, for the optimal measurement of ADC values, patients
withpriorlarge-coreneedlebiopsymustbeexcludedbecause
the blood may aﬀect the ADC. And then, we consider that
the ROI must cover the enhancing area as large as possible
avoiding necrosis or scar to correctly reﬂect the cellular
density of the tumor.
5. Conclusion
Despite the small number of cases, our ﬁndings suggest
that enhancement ratios on dynamic MR imaging reﬂect
the growth patterns of invasive ductal breast carcinomas,
including the cellular density. The cellular density and
cancer stroma also appear to be closely correlated with
ADC values. Both DW imaging and dynamic studies provide
detailed information about invasive breast carcinomas, and
our results demonstrate the potential for use of DWI in the
assessment of treatment for invasive ductal carcinoma.
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